Some endorsements seem so natural, they're hardly worth broadcasting. Infamous pharma bro Martin Shkreli endorsing Donald Trump for president is one of them.

I haven't been called by the Trump camp. I support him vs. Hillary. He should find a VP candidate who is seasoned in politics, an ugly game.

— Martin Shkreli (@MartinShkreli) May 27, 2016

SEE ALSO: Trump on climate: He's even worse than we thought

Shkreli, pictured above, is a man many consider a slimeboat corporate #dudebruh who made a name for himself in business but is now better known for almost everything else about him. He's been called "the most hated man in America." He has made oceans of cash in part by raising the price of a crucial AIDS-fighting drug from $13.50 a pop to $750. He has called Washington politicians a bunch of "imbeciles." He got into a feud with a founding member of Wu-Tang Clan. He is always tweeting about how awesome he is. 

Donald Trump, pictured below, is one of the most hated presidential candidates the nation has ever seen. He has bolstered his brand with properties built by undocumented immigrants who were barely paid. He has called members of Congress dumb and "weak." He once got into a long-running feud with comedian and television personality Rosie O'Donnell that hasn't really ended. He is always tweeting about how awesome he is.

Republican presidential candidate Donald Trump speaks during a rally at the Anaheim Convention Center, on May 25, in Anaheim, California.

Image: AP Photo/Jae C. Hong

The similarities were not lost on the Twitterverse.

@MartinShkreli you would be a perfect VP choice for Trump— both douchebags

— Gator Beau (@BeauLaVergne) May 27, 2016

@MartinShkreli My man Martin is down with Trump. Good, I'm not sure my psyche could have handle anything else than that outcome

— Anti_PC_Culture (@Anti_PC_Culture) May 27, 2016

@MartinShkreli The most hated man in America endorsing the second most hated man

— The Monster (@boris3324) May 27, 2016

Only 164 days until the election.

Have something to add to this story? Share it in the comments.